<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[QRP Research]]></title><description><![CDATA[QRP Research peptides and laboratory materials in the UK. Independently tested batches, COAs, premium quality and reliable UK dispatch]]></description><link>https://www.qrpresearch.com/blog</link><generator>RSS for Node</generator><lastBuildDate>Mon, 28 Sep 2026 18:52:34 GMT</lastBuildDate><atom:link href="https://www.qrpresearch.com/blog-feed.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[GHRP-2 Research Guide: Growth Hormone, Appetite and Evidence]]></title><description><![CDATA[Learn what GHRP-2 studies show about GH release and appetite, where benefit claims exceed the evidence, and what a research COA can establish.]]></description><link>https://www.qrpresearch.com/post/ghrp-2-research-guide</link><guid isPermaLink="false">6aba9a2214eeeb87d4d10035</guid><pubDate>Mon, 28 Sep 2026 16:47:30 GMT</pubDate><dc:creator>Kamil Kurpias</dc:creator></item><item><title><![CDATA[CJC-1295 with DAC Research Guide: GH, IGF-1 and Evidence]]></title><description><![CDATA[Explore CJC-1295 with DAC research, measured GH and IGF-1 responses, the limits of benefit claims, and how to interpret batch documentation.]]></description><link>https://www.qrpresearch.com/post/cjc-1295-dac-research-guide</link><guid isPermaLink="false">6aba9a2214eeeb87d4d10036</guid><pubDate>Mon, 28 Sep 2026 16:47:30 GMT</pubDate><dc:creator>Kamil Kurpias</dc:creator></item><item><title><![CDATA[Ipamorelin Research Guide: Selectivity, Potential Benefits and Evidence]]></title><description><![CDATA[Understand ipamorelin research, the animal findings behind selectivity claims, human gastrointestinal trial results, and important safety limitations.]]></description><link>https://www.qrpresearch.com/post/ipamorelin-research-guide</link><guid isPermaLink="false">6aba9a2214eeeb87d4d10037</guid><pubDate>Mon, 28 Sep 2026 16:47:30 GMT</pubDate><dc:creator>Kamil Kurpias</dc:creator></item><item><title><![CDATA[ARA-290 Research Guide: Cibinetide, Potential Benefits and Evidence]]></title><description><![CDATA[Understand ARA-290 research, findings in sarcoidosis-associated small-fibre neuropathy, evidence limitations and batch documentation.]]></description><link>https://www.qrpresearch.com/post/ara-290-research-guide</link><guid isPermaLink="false">6aba983cd75d3a17b1c58882</guid><pubDate>Mon, 28 Sep 2026 16:39:24 GMT</pubDate><dc:creator>Kamil Kurpias</dc:creator></item><item><title><![CDATA[Retatrutide Research Guide: Triple-Receptor Biology and Clinical Evidence]]></title><description><![CDATA[Explore retatrutide's three receptor targets, a landmark obesity trial, research limitations and how to read documentation for the 60 mg material.]]></description><link>https://www.qrpresearch.com/post/retatrutide-research-guide</link><guid isPermaLink="false">6aba983cd75d3a17b1c58881</guid><pubDate>Mon, 28 Sep 2026 16:39:24 GMT</pubDate><dc:creator>Kamil Kurpias</dc:creator></item><item><title><![CDATA[Tirzepatide Research Guide: GIP, GLP-1 and the Evidence]]></title><description><![CDATA[Read about tirzepatide's receptor biology, clinical evidence, the distinction between licensed medicines and research material, and COA checks.]]></description><link>https://www.qrpresearch.com/post/tirzepatide-research-guide</link><guid isPermaLink="false">6aba983cd75d3a17b1c58880</guid><pubDate>Mon, 28 Sep 2026 16:39:24 GMT</pubDate><dc:creator>Kamil Kurpias</dc:creator></item><item><title><![CDATA[TB-500 Research Guide: Potential Benefits, Evidence and COAs]]></title><description><![CDATA[Explore TB-500 research, potential benefits under investigation, the difference from thymosin beta-4 and how to review laboratory documentation.]]></description><link>https://www.qrpresearch.com/post/tb-500-research-guide</link><guid isPermaLink="false">6aba8d68949eb72025221623</guid><pubDate>Mon, 28 Sep 2026 16:15:02 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/5a2b22_6e28d4d9668047a9914623b53e7b1eaf~mv2.png/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Kamil Kurpias</dc:creator></item><item><title><![CDATA[BPC-157 Research Guide: Evidence, Limitations and COAs]]></title><description><![CDATA[Understand BPC-157 research, the limits of human evidence and how to review batch documentation. For laboratory research only.]]></description><link>https://www.qrpresearch.com/post/bpc-157-research-guide</link><guid isPermaLink="false">6aba758ad50ec869da89c3e7</guid><pubDate>Mon, 28 Sep 2026 14:18:53 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/5a2b22_cde4b359755041be909d4f9cf339ef1d~mv2.png/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Kamil Kurpias</dc:creator></item></channel></rss>